The therapy with GLP-1 agonists could improve fertility either by increasing LH surge in hypothalamus-pituitary inhibition caused by obesity-related estrogen surplus or by reducing high LH levels accompanying hyperinsulinemia [50]. The gene discussed is GCG; the disease is obesity due to melanocortin 4 receptor deficiency.